Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease

BACKGROUND: Alzheimer’s disease (AD) is a chronic progressive neurodegenerative disease impacting an estimated 44 million adults worldwide. The causal pathology of AD (accumulation of amyloid-beta and tau), precedes hallmark symptoms of dementia by more than a decade, necessitating development of ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasanthakumar, Aparna, Davis, Justin W., Idler, Kenneth, Waring, Jeffrey F., Asque, Elizabeth, Riley-Gillis, Bridget, Grosskurth, Shaun, Srivastava, Gyan, Kim, Sungeun, Nho, Kwangsik, Nudelman, Kelly N. H., Faber, Kelley, Sun, Yu, Foroud, Tatiana M., Estrada, Karol, Apostolova, Liana G., Li, Qingqin S., Saykin, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294637/
https://www.ncbi.nlm.nih.gov/pubmed/32539856
http://dx.doi.org/10.1186/s13148-020-00864-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294637/
https://www.ncbi.nlm.nih.gov/pubmed/32539856
http://dx.doi.org/10.1186/s13148-020-00864-y

Ejemplares similares